Brigit Biofarmaka Teknologi Tbk. vs Saptausaha Gemilangindah Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Saptausaha Gemilangindah Tbk. trades at Rp35 (market cap 273.14B, 2.31M 24h volume). The key difference: Saptausaha Gemilangindah Tbk. is the larger of the two by market cap, and Saptausaha Gemilangindah Tbk. is more actively traded (2.31M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SAGE | |
|---|---|---|
Market Cap | 172.82B | 273.14B |
Volume | 592.2K | 2.31M |
Lot | 5.92K | 23.08K |
Turnover | 147.05M | 80.36M |
Average Price | 248.31 | 34.82 |
Value | 147.05M | 80.36M |
Indicative Equilibrium Price | 254 | 35 |
Indicative Equilibrium Volume | 10 | 1.78K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Saptausaha Gemilangindah Tbk (the Company) was established on July 29, 1992 based onNotarial Deed No. 63 of Sulaimansjah, S.H., notary in Jakarta. The Company started its commercial operations on 2017.
Read more on SAGE →